| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|
Collaboration revenue | |||||||||
900 | 1,049 | 984 | 1,055 | 370 | - | 449 | 172 | - | - |
Operating expenses: | |||||||||
General and administrative | |||||||||
3,989 | 3,101 | 2,776 | 3,419 | 3,444 | 4,467 | 2,895 | 2,230 | 1,703 | 889 |
Research and development | |||||||||
9,906 | 6,965 | 5,302 | 6,867 | 8,353 | 6,998 | 10,313 | 5,414 | 5,819 | 2,461 |
Total operating expenses | |||||||||
13,895 | 10,066 | 8,078 | 10,286 | 11,797 | 11,465 | 13,208 | 7,644 | 7,522 | 3,350 |
Loss from operations | |||||||||
-12,995 | -9,017 | -7,094 | -9,231 | -11,427 | -10,943 | -12,759 | -7,472 | -7,522 | -3,350 |
Other income: | |||||||||
Interest income | |||||||||
203 | 109 | 99 | 96 | 114 | - | 102 | 170 | - | - |
Other income and expense, net | |||||||||
-26 | -12 | 5 | 26 | 46 | 66 | 98 | 2 | -1 | - |
Total other income | |||||||||
177 | 96 | 104 | 122 | 160 | 170 | 200 | 172 | -1 | - |
Loss before provision for income taxes | |||||||||
- | - | -6,990 | -9,109 | - | - | -12,559 | -7,300 | - | - |
Provision for income taxes | |||||||||
- | - | - | 413 | - | - | - | - | - | - |
Net loss | |||||||||
-12,818 | -8,919 | -6,990 | -9,522 | -11,267 | -11,606 | -12,551 | -7,300 | -7,523 | -3,350 |
Unrealized gains (losses) from available-for-sale securities | |||||||||
259 | -10 | 11 | 3 | -3 | - | -20 | - | - | - |
Comprehensive loss | |||||||||
-12,559 | -8,919 | -6,990 | -9,519 | -11,270 | -11,589 | -12,579 | -7,300 | -7,523 | - |
Net loss per common share – basic and diluted | |||||||||
-0.48 | -0.35 | -0.31 | -0.46 | -0.54 | -0.59 | -0.62 | -0.36 | -0.37 | -0.31 |
Weighted average common shares outstanding – basic and diluted | |||||||||
26,569 | 24,177 | 22,450 | 20,821 | 20,718 | 20,209 | 20,132 | 20,130 | 20,063 | 10,636 |